Biologic Agents and the Treatment of Autoimmune Disorders
by
Mary Calvagna, MS
The immune system plays a vital role in keeping the body healthy. The system includes blood cells and organs that work to fight and remove germs. Sometimes the immune system misfires. It begins to attack healthy tissue in the body. This is called an autoimmune disorder. Over time this kind of disorder can cause severe damage to tissue such as joints or organs. Treatment may help to slow or stop this process. Biologic medicine is one part of treatment. This medicine is made with proteins from living cells. It allows the medicine to:
Biologic Agents and the Treatment of Autoimmune DisordersThe biologic agent can limit part of the immune system. This can slow or stop damage to healthy tissue. Autoimmune disorders that have been treated with biologic agents include:
Side Effects of Biologic AgentsSide effects will depend on:
The body’s reaction can also vary. Some possible side effects of biologic therapies include:
If your doctor recommends biologic therapy:
A Step Forward in MedicineMany biologic agents have been approved by the FDA. Many more are being developed.
RESOURCES:National Multiple Sclerosis Society
http://www.nationalmssociety.org National Psoriasis Foundation
http://www.psoriasis.org References:Autoimmune diseases fact sheet. Office on Women's Health website. Available at:
...(Click grey area to select URL) Updated July 16, 2012. Accessed June 24, 2016. Biologic disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis. EBSCO DynaMed website. Available at:
...(Click grey area to select URL) Updated July 9, 2014. Accessed July 18, 2014. Donahue KE, Gartlehner G, Jonas DE, et al. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis.
Ann Intern Med. 2008; 148.
Efalizumab (marketed as Raptiva) information. US Food and Drug Administration website. Available at:
...(Click grey area to select URL) Updated July 10, 2015. Accessed June 24, 2016. Keystone EC, et al. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis Rheum. 2004;50(2):353-63.
Moderate to severe psoriasis: biologic drugs. National Psoriasis Foundation Web site. Available at:
...(Click grey area to select URL) Accessed June 24, 2016. National drug code directory. US Food and Drug Administration website. Available at:
...(Click grey area to select URL) Updated April 22, 2016. Accessed June 24, 2016. Last reviewed June 2018 by Michael Woods, MD
Last Updated: 7/3/2018 |
||||||||||||||||||||||
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition. To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days. |